✦ LIBER ✦

A pharmacogenetic study of docetaxel and thalidomide in patients with castration-resistant prostate cancer using the DMET genotyping platform

✍ Scribed by Deeken, J F; Cormier, T; Price, D K; Sissung, T M; Steinberg, S M; Tran, K; Liewehr, D J; Dahut, W L; Miao, X; Figg, W D

Book ID: 118044508
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 358 KB
Volume: 10
Category: Article
ISSN: 1470-269X
DOI: 10.1038/tpj.2009.57

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel reintroduction in patients wit

Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study

✍ Jean-Christophe Eymard; Stéphane Oudard; Gwenaelle Gravis; Jean-Marc Ferrero; Ch 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB

A phase I study of oral panobinostat alo

A phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer

✍ Dana Rathkopf; Bryan Y. Wong; Robert W. Ross; Aseem Anand; Erika Tanaka; Margare 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 378 KB

Randomized phase II study of danusertib

Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failure

✍ Hielke J. Meulenbeld; Jean P. Bleuse; Elio M. Vinci; Eric Raymond; Giordano Vita 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB

223 VERSICAN IS A PROMISING CANDIDATE BI

223 VERSICAN IS A PROMISING CANDIDATE BIOMARKER IN THE COMBINATION OF DOCETAXEL WITH THALIDOMIDE AS SECOND LINE CHEMOTHERAPY IN CASTRATION-RESISTANT PROSTATE CANCER AFTER DOCETAXEL RESISTANCE

✍ Shiina, Hiroaki; Yasumoto, Hiroaki; Hiraki, Miho; Arichi, Naoko; Mitsui, Yozo; H 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 62 KB

Phase I trial with a combination of doce

Phase I trial with a combination of docetaxel and 153Sm-lexidronam in patients with castration-resistant metastatic prostate cancer

✍ Jianqing Lin; Victoria J. Sinibaldi; Michael A. Carducci; Samuel Denmeade; Danny 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 296 KB

Randomised phase II/III study of docetax

Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)

✍ H.J. Meulenbeld; E.D. van Werkhoven; J.L.L.M. Coenen; G.J. Creemers; O.J.L. Loos 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 674 KB